These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
481 related items for PubMed ID: 8650077
1. Regulation of prostatic growth and function by peptide growth factors. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G, Klocker H. Prostate; 1996 Jun; 28(6):392-405. PubMed ID: 8650077 [Abstract] [Full Text] [Related]
10. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions. Pavone-Macaluso M, Carruba G, Castagnetta L. Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681 [Abstract] [Full Text] [Related]
12. An orthotopic model for the study of growth factors in the ventral prostate of the rat: effects of epidermal growth factor and basic fibroblast growth factor. Marengo SR, Chung LW. J Androl; 1994 Mar; 15(4):277-86. PubMed ID: 7982795 [Abstract] [Full Text] [Related]
13. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia. Myers RB, Kudlow JE, Grizzle WE. Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115 [Abstract] [Full Text] [Related]
14. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Gao J, Arnold JT, Isaacs JT. Cancer Res; 2001 Jul 01; 61(13):5038-44. PubMed ID: 11431338 [Abstract] [Full Text] [Related]
18. Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II. Song K, Cornelius SC, Danielpour D. Cancer Res; 2003 Aug 01; 63(15):4358-67. PubMed ID: 12907605 [Abstract] [Full Text] [Related]
19. Increased expression of fibroblast growth factor 6 in human prostatic intraepithelial neoplasia and prostate cancer. Ropiquet F, Giri D, Kwabi-Addo B, Mansukhani A, Ittmann M. Cancer Res; 2000 Aug 01; 60(15):4245-50. PubMed ID: 10945637 [Abstract] [Full Text] [Related]
20. Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Jin C, Wang F, Wu X, Yu C, Luo Y, McKeehan WL. Cancer Res; 2004 Jul 01; 64(13):4555-62. PubMed ID: 15231666 [Abstract] [Full Text] [Related] Page: [Next] [New Search]